Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 12:41 AM ET

Food and Staples Retailing

Company Overview of New England Compounding Pharmacy, Inc.

Company Overview

New England Compounding Pharmacy, Inc., a compounding-only pharmacy, provides compounded medications and services to patients and prescribers. It offers specialty medications for hospitals in the areas of interventional pain management, radiology/nuclear medicine, surgery, ophthalmology, emergency, miscellaneous, retina, and aesthetics. The company was incorporated in 1998 and is based in Framingham, Massachusetts.

697 Waverly Street

Framingham, MA 01702

United States

Founded in 1998





Key Executives for New England Compounding Pharmacy, Inc.

New England Compounding Pharmacy, Inc. does not have any Key Executives recorded.

New England Compounding Pharmacy, Inc. Key Developments

Victims of Contaminated Steroid Injections to Share $100 Million Settlement Against New England Compounding Center, Attorneys with Janet, Jenner & Suggs

Victims of contaminated steroid injections who sued in federal courts will share a $100 million settlement against the New England Compounding Center (NECC), attorneys with Janet, Jenner & Suggs, LLC. The settlement was tentatively agreed upon last December. It was officially filed with the bankruptcy court, which must approve it. The bankruptcy court is overseeing NECC's bankruptcy, filed in 2012. The settlement is with NECC, NECC's owners, related companies, and insurers. The Case is In re: New England Compounding Pharmacy Inc. Products Liability Litigation, MDL No. 2419, in the U.S. Judicial Panel on Multidistrict Litigation (MDL). The announced settlement covers all claims against NECC filed in with the bankruptcy claims administrator.

Plaintiffs' Steering Committee Announces Settlement with the Owners, Operators and Insurers of the New England Compounding Pharmacy, Inc

The Court-appointed Plaintiffs' Steering Committee (PSC), charged with speaking for hundreds of victims of tainted steroids produced by the New England Compounding Pharmacy, Inc. announced a preliminary settlement with the owners, operators and insurers of the bankrupt NECC. A conditional agreement has been reached between bankruptcy trustee Paul D. Moore, the PSC and the Unsecured Creditors Committee under which the Cadden and Conigliaro families, the insurers of NECC and related company Ameridose, have promised to pay to a compensation fund an amount that may exceed $100 million. This fund will allow victims who received injections of tainted steroids made by NECC to seek a measure of justice against those wrongdoers. The agreements are not final, require due diligence on the part of the PSC to ensure the rights to victims are protected under these agreements, and will be conditional upon approval by creditors and a federal court for fairness and adequacy.

Similar Private Companies By Industry

Company Name Region
Jamail's Fresh Market, LP United States
Vatee Inc. United States
Wallace & Owens Store Inc United States
Testa Produce, Inc. United States
Madison Livestock Sales Co. Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact New England Compounding Pharmacy, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at